Show Summary Details
Page of

Bronchiectasis 

Bronchiectasis

Chapter:
Bronchiectasis
Author(s):

R.D. Bilton

DOI:
10.1093/med/9780199204854.003.1809_update_001

Update:

Management—revised recommendations on treatment of patients with chronic Pseudomonas aeruginosa infection; discussion of use of azithromycin, with antimicrobial and immunomodulatory effects that can reduce exacerbations in selected patients.

Updated on 30 May 2013. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 24 March 2017

Bronchiectatic lung contains permanently dilated subsegmental airways that are inflamed, tortuous, and often partially or totally obstructed with secretions. It arises as a result of the combination of an infectious insult with associated impaired clearance mechanisms: local obstruction and infection distal to the obstruction are both required. Causes include developmental defects, immune deficiency, mucociliary clearance defects and mechanical obstruction, but in many cases (40–60%) the cause is unknown.

Clinical features—bronchiectasis should be suspected when there is a history of persistent cough productive of mucopurulent or purulent sputum throughout the year. About 80% of patients have upper respiratory tract symptoms (postnasal drip, chronic sinus sepsis, recurrent ear infections). Clinical examination is often normal, although ‘classical’ severe cases show finger clubbing and widespread coarse crackles.

Investigation—the ‘gold standard’ for diagnosis is high-resolution CT of the chest, which reveals abnormal thick-walled and dilated bronchi. The chest radiograph is normal in at least 50% of cases, but abnormal thickened and dilated bronchi may produce tramline opacities and ring shadows. Investigations to determine the underlying cause will be determined by clinical suspicion but may include testing for cystic fibrosis, immunoglobulins, bronchoscopy, nasal nitric oxide, nasal brushing/biopsy, and tests for allergic bronchopulmonary aspergillosis. Disease status is assessed by high-resolution CT, lung function tests, sputum culture, and measurement of inflammatory markers.

Management—involves the treatment of the specific underlying cause (when possible) and treatment of the bronchiectasis itself, with the most important elements being sputum clearance by physiotherapy and antimicrobials, which need to be given in high dose, often by the nebulized or parenteral routes, and with careful assessment of response in each individual patient. Surgery can be a curative for patients with single lobe, focal bronchiectasis secondary to bronchial obstruction, and lobar resection may also be indicated for otherwise uncontrollable bleeding, or if it is felt that a particular lobe is acting as a ‘sump’ of infection which prevents good control of symptoms with medical therapy. Lung transplantation may be appropriate in carefully selected cases.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.